ESC 365 - Effects of pharmacological inhibition of Sphingosine Kinase 1 on cardiovascular function in angiotensin II-dependent hypertension in vivo

ESC Premium Access

Effects of pharmacological inhibition of Sphingosine Kinase 1 on cardiovascular function in angiotensin II-dependent hypertension in vivo

Session: Poster Session 2 - Pulmonary hypertension

Topic: Drugs, Drug Targets

Speaker: Ms E. Jozefczuk (Krakow, PL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Ms Ewelina Jozefczuk

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

0 follower

7 more presentations in this session

Pulmonary arterial hypertension induced by a novel twice-intraperitoneal injection of monocrotaline

Speaker: Mr W. Zhuang (Fuzhou, CN)

Unilateral ischemia of the carotid bodies changes sympathetic nervous system activity and leads to moderate pulmonary hypertension in rats

Speaker: Mr M. Markov (Moscow, RU)

Excessive proliferations of vascular smooth muscle cells derived from induced pluripotency stem cells in pulmonary arterial hypertension

Speaker: Professor S. Sung (Taipei, TW)

Functional and anatomical connectivity from the dorsomedial hypothalamus to the ventral medullary cardiovascular regions: possible neural substrate mediating stress-induced sympathoexcitation.

Speaker: Doctor Y. Kono (Yamanashi, JP)

Contribution of surface nucleolin to vascular remodeling of pulmonary arterial hypertension

Speaker: Doctor D. Kinoshita (Yamagatz, JP)

Access the full session

Poster Session 2 - Pulmonary hypertension

Speakers: Ms E. Jozefczuk, Mr W. Zhuang, Mr M. Markov, Professor S. Sung, Doctor Y. Kono...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources